38836 Federal Register / Vol. 72, No.

135 / Monday, July 16, 2007 / Notices

Trans # Acquiring Acquired Entities

20071583 .........................
20071590 .........................
20071593 .........................
20071597 .........................
20071598 .........................
20071601 .........................
20071607 .........................
William H. Gates, III ..........................
News Corporation ..............................
Kellwood Company ...........................
Perry Partners International, Inc .......
Perry Partners, L.P ............................
Pro Acquisition Corporation ..............
TD AMERITRADE Holding Corpora-
tion.
Dynegy Inc ........................................ CoGen Lyondell, LLC.
Photobucket.com, Inc ........................ Photobucket.com, Inc.
Hanna Andersson Corporation .......... Hanna Andersson Corporation.
Universal American Financial Corp ... Universal American Financial Corp.
Universal American Financial Corp ... Universal American Financial Corp.
The Home Depot, Inc ........................ CND Holdings, Inc., HD Supply, Inc.,
Homer TLC, Inc.
Fiserv, Inc .......................................... Fiserv Trust Company.

Transactions Granted Early Termination—07/03/2007

20070837 .........................
20070838 .........................
20071506 .........................
20071511 .........................
20071588 .........................
20071599 .........................
20071602 .........................
Hanover Compressor Company ........
Universal Compression Holdings, Inc
KASLION S.a.r.L ...............................
J&F Participacoes S.A ......................
Cleveland-Cliffs Inc ...........................
C/R Stallion Investment Partnership,
L.P.
C/R Stallion Investment Partnership,
L.P.
Universal Compression Holdings, Inc
Hanover Compressor Company ........
DSP Group Inc ..................................
Hicks, Muse, Tate & Furst Equity
Fund V, L.P.
PinnOak Resources, LLC ..................
Terry G. Bailey ..................................
Envirovac, Ltd ....................................
Universal Compression Holdings,
Inc.
Hanover Compressor Company.
DSP Group Inc.
Swift Foods Company.
PinnOak Resources, LLC.
Salty’s Manufacturing, Ltd., Salty’s
Well Hill No. 1, Ltd., Salty’s Well
Parker No. 1, Ltd., Salty’s Well
Service, Ltd.
Salty’s Manufacturing, Ltd., Salty’s
Well Hill No. 1, Ltd., Salty’s Well
Johnson No. 1, Ltd., Salty’s Well
Johnson No. 2, Ltd., Salty’s Well
Johnson No. 3, Ltd., Salty’s Well
Johnson No. 4, Ltd., Salty’s Well
Nacogdoches 1, Ltd., Salty’s Well
Panola 1, Ltd., Salty’s Well Parker
No. 1, Ltd., Salty’s Well Service,
Ltd., Salty’s Well Shelby No. 1,
Ltd.

Transactions Granted Early Termination—07/05/2007

20071519 ......................... Carlyle Partners IV, L.P .................... JP Morgan Chase & Co .................... Niagara Holdings, Inc.

Transactions Granted Early Termination—07/06/2007

20071520 ......................... Saudi Basic Industries Corporation ... General Electric Company ................ GE Entities.

FOR FURTHER INFORMATION CONTACT: SUMMARY: Notice is hereby given that
Sandra M. Peay, Contact Representative, the Office of Research Integrity (ORI)
or Renee Hallman, Contact and the Assistant Secretary for Health
Representative. Federal Trade have taken final action in the following
Commission, Premerger Notification case:
Office, Bureau of Competition, Room H– Kristin Roovers, Ph.D., University of
303, Washington, DC 20580, (202) 326– Pennsylvania: Based on an investigation
3100. conducted by the University of
By direction of the Commission. Pennsylvania (UP) and additional
Donald S. Clark, analysis and information obtained by
the Office of Research Integrity during
Secretary.
its oversight review, the U.S. Public
[FR Doc. 07–3435 Filed 7–13–07; 8:45 am]
Health Service (PHS) found that Kristin
BILLING CODE 6750–01–M
Roovers, Ph.D., former postdoctoral
fellow, Departments of Medicine, Cell
and Developmental Biology, and
Pharmacology, and Howard Hughes
DEPARTMENT OF HEALTH AND
Medical Institute, and former graduate
HUMAN SERVICES
student, Department of Pharmacology,
Office of the Secretary UP, engaged in misconduct in science in
hsrobinson on PROD1PC76 with NOTICES
Diseases (NIDDK), NIH, grants P30
DK52574 and R01 DK066886, National
Cancer Institute (NCI), NIH, grant R01
CA72639, and National Institute of
General Medical Sciences (NIGMS),
NIH, grants R01 GM48224, R01
GM58224, R01 GM51878, and R01
GM69064.
Dr. Roovers’ manipulations and
falsification of data were extensive,
encompassing 19 panels of Western blot
data, appearing in 11 figures in 3
publications from her research as a
graduate student and her first
postdoctoral position and in 9 panels of
immunoblot data in 8 figures of an
unpublished manuscript.
Specifically, the findings involved
falsification by duplication and reuse of
immunoblot data to misrepresent the

research funded by National Heart, results as data from different

Findings of Misconduct in Science Lung, and Blood Institute (NHLBI), experiments that had been reported in
National Institutes of Health (NIH), the following manuscript and three
AGENCY: Office of the Secretary, HHS. grants R01 HL061567, P50 HL057278, publications:
ACTION: Notice. and T32 HL07873, National Institutes of • Figures 2C, 3C, 4D, 4E, 6C, 7B, and
Diabetes and Digestive and Kidney supplement Figures 1, 2B, and 3B in a

VerDate Aug<31>2005 16:59 Jul 13, 2007 Jkt 211001 PO 00000 Frm 00025 Fmt 4703 Sfmt 4703 E:\FR\FM\16JYN1.SGM 16JYN1
 Federal Register / Vol. 72, No. 135 / Monday, July 16, 2007 / Notices
manuscript submitted to the Journal of
Clinical Investigation entitled: ‘‘Akt1
promotes physiologic, but antagonizes
pathologic, cardiac growth.’’
• Figures 3A, 3C, and 4A in: Welsh,
C.F., Roovers, K., Villanueva, J., Liu, Y.,
Schwartz, M.A., & Assoian, R.K.
‘‘Timing of cyclin D1 expression within
G1 phase is controlled by Rho.’’ Nature
Cell Biology 3(11):950–957, 2001.
• Figures 1, 2A, 2B, 3A, 3C, 4A, 4B,
6C, 6D, and 6E in: Roovers, K., &
Assoian, R.K. ‘‘Effects of rho kinase and
actin stress fibers on sustained
extracellular signal-regulated kinase
activity and activation of G(1) phase
cyclin-dependent kinases.’’ Mol. Cell
Biol. 23(12):4283–4294, 2003. Retracted
in Mol. Cell Biol. 26(13):5203, July 2006.
• Figures 1C, 2C, 5B, 5D, 6B and 6D
in: Roovers, K., Klein, E.A., Castagnino,
P., & Assoian, R.K. ‘‘Nuclear
translocation of LIM kinase mediates
Rho-Rho kinase regulation of cyclin D1
expression.’’ Developmental Cell 5
(2):273–284, 2003. Retracted in
Developmental Cell 10(5):681, May
2006.
Corrections were recommended by UP
for the Nature Cell Biology paper.
Dr. Roovers’ falsified Western blot
data from the publications in Nature
Cell Biology and from Developmental
Cell were included in NIH grant
applications CA 72639–07 and GM
69064–01.
ORI has implemented the following
administrative actions for a period of
five (5) years, beginning on June 7, 2007:
(1) Dr. Roovers is debarred from
eligibility for any contracting or
Type of respondents
Women Seeking Health Care Services ..........
Dated: July 9, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–13730 Filed 7–13–07; 8:45 am]
BILLING CODE 4163–18–P
hsrobinson on PROD1PC76 with NOTICES
VerDate Aug<31>2005 16:59 Jul 13, 2007 Jkt 211001
subcontracting with any agency of the
United States Government and from
eligibility or involvement in
nonprocurement programs of the United
States Government referred to as
‘‘covered transactions’’ as defined in
HHS’ implementation of OMB
Guidelines to Agencies on
Governmentwide Debarment and
Suspension at 2 CFR part 376, et seq.;
and
(2) Dr. Roovers is prohibited from
serving in any advisory capacity to PHS,
including but not limited to service on
any PHS advisory committee, board,
and/or peer review committee, or as a
consultant.
FOR FURTHER INFORMATION CONTACT:
Director, Division of Investigative
Oversight, Office of Research Integrity,
1101 Wootton Parkway, Suite 750,
Rockville, MD 20852, (240) 453–8800.
Chris B. Pascal,
Director, Office of Research Integrity.
[FR Doc. E7–13703 Filed 7–13–07; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–07–06BM]
Agency Forms Undergoing Paperwork;
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
respondents
Eligibility Script for Pretest .............................
Baseline Questionnaire for Pretest ................
Follow-up Questionnaire Pretest ....................
Eligibility Script for Main Study ......................
Baseline Questionnaire for Main Study .........
Follow-up Questionnaire Main Study .............
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
PO 00000 Frm 00026 Fmt 4703 Sfmt 4703 E:\FR\FM\16JYN1.SGM
38837
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an e-
mail to: omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974.
Notice of Correction
Title of Project
Randomized Controlled Trial of
Routine Screening for Intimate Partner
Violence—New—National Center for
Injury Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Description of Correction
A 30-day Federal Register Notice was
published on June 25, 2007 (Vol. 72, No.
121, pp. 34691–34692) describing
proposed activities with total estimated
annualized burden of 717.7 hours. The
annualized total burden hour estimate is
correct, however, due to a clerical
oversight, the table of Estimated
Annualized Burden Hours contained
non-annualized figures for the Number
of Respondents (i.e., project totals). The
corrected table appears below. The total
estimated annualized burden hours are
717.7.
Average
Number of
Number of burden
responses per
per response
respondent (in hours)
70 1 1/60
65 1 15/60
59 1 12/60
1,533 1 1/60
1,227 1 17/60
860 1 22/60
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: National Evaluation of the
Protection and Advocacy for
Individuals with Mental Illness
(PAIMI) Program—NEW
In recognition that systematic
evaluation of this and other government
programs are part of good management
16JYN1